Gabriel Medrano-Ramírez

492 total citations
12 papers, 354 citations indexed

About

Gabriel Medrano-Ramírez is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Gabriel Medrano-Ramírez has authored 12 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 5 papers in Immunology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Gabriel Medrano-Ramírez's work include Rheumatoid Arthritis Research and Therapies (4 papers), Systemic Sclerosis and Related Diseases (3 papers) and Mast cells and histamine (2 papers). Gabriel Medrano-Ramírez is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (4 papers), Systemic Sclerosis and Related Diseases (3 papers) and Mast cells and histamine (2 papers). Gabriel Medrano-Ramírez collaborates with scholars based in Mexico, United States and Argentina. Gabriel Medrano-Ramírez's co-authors include Rubén Burgos‐Vargas, Jorge Morales‐Torres, Elliott B. Grossbard, Ara Dikranian, Frederick T. Murphy, Michael E. Weinblatt, Arthur Kavanaugh, Mónica Vázquez-Del Mercado, Lilia Andrade-Ortega and Ignacio Garcı́a-De La Torre and has published in prestigious journals such as Lara D. Veeken, Human Vaccines & Immunotherapeutics and Rheumatology International.

In The Last Decade

Gabriel Medrano-Ramírez

12 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gabriel Medrano-Ramírez Mexico	6	162	141	94	78	74	12	354
Minodora Mazur Moldova	6	113 0.7×	279 2.0×	91 1.0×	29 0.4×	92 1.2×	20	368
V. Derksen Netherlands	7	104 0.6×	293 2.1×	28 0.3×	145 1.9×	38 0.5×	11	414
Caylib Durand Canada	9	158 1.0×	41 0.3×	83 0.9×	16 0.2×	55 0.7×	15	328
Paul M. Diderichsen United States	10	45 0.3×	57 0.4×	79 0.8×	24 0.3×	90 1.2×	38	341
Sebastian Meerwein United States	8	158 1.0×	524 3.7×	126 1.3×	19 0.2×	299 4.0×	23	675
Nikolay Delev United States	9	244 1.5×	295 2.1×	27 0.3×	65 0.8×	101 1.4×	24	409
M. Lamba United States	8	138 0.9×	100 0.7×	29 0.3×	8 0.1×	76 1.0×	17	356
Francesco Mendicino Italy	12	71 0.4×	45 0.3×	127 1.4×	12 0.2×	224 3.0×	52	433
S Gentili Italy	10	162 1.0×	120 0.9×	345 3.7×	21 0.3×	399 5.4×	16	685
Laetitia Coutte France	5	61 0.4×	58 0.4×	98 1.0×	13 0.2×	46 0.6×	10	386

Countries citing papers authored by Gabriel Medrano-Ramírez

Since Specialization

Citations

This map shows the geographic impact of Gabriel Medrano-Ramírez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Medrano-Ramírez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Medrano-Ramírez more than expected).

Fields of papers citing papers by Gabriel Medrano-Ramírez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriel Medrano-Ramírez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Medrano-Ramírez. The network helps show where Gabriel Medrano-Ramírez may publish in the future.

Co-authorship network of co-authors of Gabriel Medrano-Ramírez

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriel Medrano-Ramírez. A scholar is included among the top collaborators of Gabriel Medrano-Ramírez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriel Medrano-Ramírez. Gabriel Medrano-Ramírez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Peláez‐Ballestas, Ingris, et al.. (2023). Interrupción del embarazo en nefritis lúpica: un análisis bioético desde el método integral. Reumatología Clínica. 20(1). 20–23. 1 indexed citations

Contreras-Yáñez, Irazú, Everardo Álvarez‐Hernández, Susana Aideé González‐Chávez, et al.. (2022). Factors associated to COVID-19 vaccine acceptance in Mexican patients with rheumatic diseases: A cross-sectional and multicenter study. Human Vaccines & Immunotherapeutics. 18(5). 2049131–2049131. 6 indexed citations

García-García, Conrado, Everardo Álvarez‐Hernández, Gabriel Medrano-Ramírez, et al.. (2021). Qualitative validation of audiovisual educational material for use on rheumatoid arthritis patients. Rheumatology International. 42(11). 2049–2059. 4 indexed citations

Torre, Ignacio Garcı́a-De La, Mónica Vázquez-Del Mercado, Lilia Andrade-Ortega, et al.. (2019). Autoantibodies to Mi-2 alpha and Mi-2 beta in patients with idiopathic inflammatory myopathy. Lara D. Veeken. 58(9). 1655–1661. 20 indexed citations

Mercado, Mónica Vázquez-Del, Eduardo Gómez-Bañuelos, Rosa Elena Navarro-Hernández, et al.. (2016). Detection of autoantibodies to DSF70/LEDGFp75 in Mexican Hispanics using multiple complementary assay platforms. PubMed. 8(1). 1–1. 26 indexed citations

Burgos‐Vargas, Rubén, Carlos Abud‐Mendoza, E Díaz-Jouanen, et al.. (2009). [Treatment guidelines for ankylosing spondylitis and its effect on Mexican rheumatology].. PubMed. 145(1). 41–9. 5 indexed citations

Díaz-Jouanen, E, Carlos Abud‐Mendoza, Mario Alberto Garza‐Elizondo, et al.. (2009). [Guidelines in RA treatment: concepts on safety and recommendations using anti-TNF-alpha inhibitors. Grupo de Estudio de Nuevas Terapias de Enfermedades reumáticas (GENTE)].. PubMed. 61(3). 252–66. 3 indexed citations

Rojas‐Serrano, Jorge, et al.. (2008). Menor incidencia de daño grave en órganos diana en pacientes mexicanos con esclerosis sistémica con afección cutánea difusa. Reumatología Clínica. 4(1). 3–7. 6 indexed citations

Weinblatt, Michael E., Arthur Kavanaugh, Rubén Burgos‐Vargas, et al.. (2008). Treatment of rheumatoid arthritis with a syk kinase inhibitor: A twelve‐week, randomized, placebo‐controlled trial. Arthritis & Rheumatism. 58(11). 3309–3318. 267 indexed citations

10.

Álvarez‐Hernández, Everardo, Janitzia Vázquez‐Mellado, Julio Casasola-Vargas, et al.. (2008). The Use of Glucocorticoids by Rheumatologic Patients Before Attending a Specialized Department in México. JCR Journal of Clinical Rheumatology. 14(3). 148–152. 5 indexed citations

11.

Rojas‐Serrano, Jorge, et al.. (2008). Lower Incidence of Severe Damage to Target Organs in Mexican Patients With Systemic Sclerosis and Diffuse Skin Affection. Reumatología Clínica (English Edition). 4(1). 3–7. 2 indexed citations

12.

Díaz-Jouanen, E, Carlos Abud‐Mendoza, Mario Alberto Garza‐Elizondo, et al.. (2006). [Recommendations for the medical treatment of rheumatoid arthritis].. PubMed. 57(5). 735–55. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact